Companies / Uganda
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
First Local ARV Manufacturing
September 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
In a milestone for Uganda's fledgling pharmaceutical industry, the first antiretrovirals (ARVs) will be manufactured in the country next month, ending its complete reliance on imported drugs to treat the country's considerable HIV/AIDS epidemic. Two companies - Uganda's Quality Chemicals and India's Cipla - have teamed up to produce ARVs at a new US$16mn plant in the Ugandan capital